Brexit Talks Must Prioritize Patient Access, Avoid Regulatory Divergence – EFPIA

European industry federation says patient access to new drugs must be a priority in the negotiations over the UK's exit from the EU, as must the need to ensure that the UK and EU drug regulatory systems don't diverge.